prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration
gambro lundia ab - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates
veterinary 0.9% sodium chloride- sodium chloride injection, solution
vedco, inc. - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 900 mg in 100 ml - sodium chloride injection, usp is indicated as a source of water and electrolytes. none known.
sodium chloride injection, solution
laboratorios grifols sa - sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698, sodium cation - unii:lyr4m0nh37) - sodium chloride 9 g in 1000 ml - sodium chloride injection, usp is indicated as a source of water and electrolytes. 0.9% sodium chloride injection, usp is also indicated for use as a priming solution in hemodialysis procedures. none known.
haemonetics 0.9 % sodium chloride- sodium chloride solution
haemonetics corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride 900 mg in 100 ml - sodium chloride injection, usp is indicated as a source of water and electrolytes. 0.9% sodium chloride in hemodialysis procedures. none known safety and effectiveness of sodium chloride injection, usp in pediatric patients have not been established by adequate and well controlled trials; however, the use of sodium chloride solutions in the pediatric populations is referenced in the medical literature. the warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population. do not administer unless solution is clear and seal is intact.
plasma-lyte® 148 (ph 7.4) solution for infusion
baxter holding b.v. - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate ; sodium gluconate - solution for infusion - 148 (ph 7.4) - solutions affecting the electrolyte balance; electrolytes
prismasol 2 mmol/l potassium solution for haemodialysis/haemofiltration
baxter holding b.v. - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactate; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 2 millimole(s)/litre - hemofiltrates
prismasol 4 mmol/l potassium solution for haemodialysis/haemofiltration
baxter holding b.v. - glucose (as monohydrate); magnesium chloride hexahydrate; calcium chloride dihydrate; lactic acid; sodium chloride; potassium chloride; sodium hydrogen carbonate; calcium; magnesium; sodium; chloride; lactase; hydrogen carbonate; potassium; glucose - solution for haemodialysis/haemofiltration - 4 millimole(s)/litre - hemofiltrates
sodium sulfate, potassium sulfate and magnesium sulfate- sodium sulfate, potassium sulfate, magnesium sulfate solution, concentr
affordable pharmaceuticals, llc - sodium sulfate (unii: 0ypr65r21j) (sodium cation - unii:lyr4m0nh37), potassium sulfate (unii: 1k573lc5tv) (potassium cation - unii:295o53k152), magnesium sulfate, unspecified form (unii: de08037sab) (magnesium cation - unii:t6v3lhy838) - sodium sulfate, potassium sulfate and magnesium sulfate oral solution is indicated for cleansing of the colon as a preparation for colonoscopy in adult and pediatric patients 12 years of age and older. sodium sulfate, potassium sulfate and magnesium sulfate oral solution is contraindicated in the following conditions: - gastrointestinal obstruction or ileus [see warnings and precautions ( 5.6)] - bowel perforation [see warnings and precaution ( 5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in sodium sulfate, potassium sulfate and magnesium sulfate oral solution risk summary there are no available data on sodium sulfate, potassium sulfate and magnesium sulfate oral solution use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. animal reproductive studies have not been conducted with sodium sulfate,
sodium bicarbonate 500 mg
rekah pharmaceutical industry ltd, israel - sodium bicarbonate - tablets - sodium bicarbonate 500 mg - sodium bicarbonate - sodium bicarbonate - antacid.
sodium chloride 0.45 % injection
teva medical marketing ltd. - sodium chloride - solution for infusion - sodium chloride 450 mg / 100 ml - sodium chloride - sodium chloride - supply of water and electrolytes.